Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results)

by Jerry Bagel, John Nia, Peter W. Hashim, Manmath Patekar, Ana de Vera, Sophie Hugot, Kuan Sheng, Summer Xia, Isabelle Gilloteau, Elisa Muscianisi, Andrew Blauvelt, Mark Lebwohl
Published 2018-10-01

Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis

by Lin Cai, Jian-Zhong Zhang, Xu Yao, Jun Gu, Quan-Zhong Liu, Min Zheng, Shi-Fa Zhang, Jin-Hua Xu, Cheng-Xin Li, Hao Cheng, Qing Guo, Wei-Li Pan, Shen-Qiu Li, Ruo-Yu Li, Zai-Pei Guo, Zhi-Qi Song, Shan-Shan Li, Xiu-Qin Dong, Linda Wang, Rong Fu, Pascaline Regnault, Pascal Charef, Rafal Mazur, Manmath Patekar, Jing Ni, Li-Shao Guo
Published 2020-11-01